Add Company
Join Now

Apriori Bio Revenue and Competitors

License our Company Data API

Location

$51M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Apriori Bio's estimated annual revenue is currently $3M per year.(i)
  • Apriori Bio's estimated revenue per employee is $77,500
  • Apriori Bio's total funding is $51M.

Employee Data

  • Apriori Bio has 39 Employees.(i)
  • Apriori Bio grew their employee count by 11% last year.

Apriori Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Co-Founder and Chief Innovation OfficerReveal Email/Phone
6
VP, BiologyReveal Email/Phone
7
Head R&D StrategyReveal Email/Phone
8
Associate DirectorReveal Email/Phone
9
Director Data ScienceReveal Email/Phone
10
Senior Director, Preclinical BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Apriori Bio?

Apriori is working to create a world where humanity is protected against viral threats. Our pioneering approach centers on a unique technology platform, which allows us to survey the entire landscape of existing and potential viral variants to design new vaccines and antibody drugs against the most threatening variants. Octavia can also inform public health policy in real time by predicting the impact of emerging variants. Apriori was founded in 2020 in Flagship Labs, a unit of Flagship Pioneering.

keywords:N/A

$51M

Total Funding

39

Number of Employees

$3M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M393%N/A
#2
$4.7M39-2%N/A
#3
$8.4M39-11%N/A
#4
$15M3934%N/A
#5
$7.6M390%N/A